APP and Alzheimer disease: For example, one of the most widely used amyloidosis models in AD-related research, double-transgenic APP/PS1 mice, exhibited microbiota alterations at a young age (3 mo), gradually escalating to more obvious alterations in the prevalence of inflammation-related bacteria at later ages (6 mo and 9 mo) [21].